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An  investigation of  the  possibility of  treating  cases  of  pneumonia 
with  specific antisera  other  than  Type  I  and  Type  II  antisera  was 
undertaken  because  clinical  results  indicated  that  pneumonia  cases 
were benefited slightly, if at all, by treatment with heterologous anti- 
sera.  For this purpose it was necessary to classify further the infect- 
ing  types  of  pneumoeocci,  to  prepare  diagnostic  antisera  for  their 
identification and specific therapeutic antisera for treatment. 
The results given in an earlier report (1) are as follows:  58 per cent of pneumo- 
coccus strains isolated from lobar pneumonia cases  in adults which did not fall 
into Types I, II and III were classified in ten types which were termed Types IV 
to XIII.  The cross-protective power of potent antisera for Types I, II and III 
against these types was tested by protection tests in mice and was found to be 
very low.  Monovalent antisera of high agglutinative and high protective value 
were prepared for these types by injecting rabbits.  Also,  monovalent antisera 
suitable for clinical  trial were prepared for five types by immunizing horses.  A 
study of the possibility of preparing suitable pulyvalent antisera was begun and 
there was an indication  that  the  potency of the  polyvalent antiserum for the 
separate types injected as compared with good monovalent antisera was lowered 
somewhat in proportion to the number of type strains injected. 
* We thank Dr. William H. Park under whose direction the pneumonia investi- 
gations have been carried out for advice and encouragement.  We acknowledge 
with thanks the assistance of Miss Marian Webster, Miss Miriam Meeker and 
Miss Katherine Blount.  This investigation was aided by grants of money from 
New  York  University  Littauer  Pneumonia  Fund  and  the  Metropolitan  Life 
Insurance Influenza Commission Fund for part of the expense. 
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The results obtained and the problems encountered in the further 
development of the investigation with the exception of the possibility 
of preparing suitable polyvalent antisera are discussed in this report. 
The findings in regard to production of polyvalent antisera will be 
given in a  separate report. 
Further Separation of Types and Correlation of Types with Severity of 
Disease 
As 42 per cent of the Group IV strains from the lobar pneumonia 
cases of adults were left unclassified and several of the strains were 
isolated from the blood stream or from the sputa of severe or fatal cases 
it seemed worth while to  carry further the  classification  of  strains. 
Antisera were prepared for strains isolated from the more severe cases. 
The strains from the first series of cases which were not used for serum 
production were discarded on account of the difficulty  of maintaining a 
large number of stock cultures intact through the summer months. 
A  classification of strains freshly isolated from cases in  the  season 
1928 and 1929 was carried out.  Strains isolated from cases of pneu- 
monia of children were also studied.  In the season 1929 and 1930 a 
new series of cultures was studied.  In 1931 only strains which were 
not classifiable or gave doubtful reactions or were wanted for special 
work  were  investigated.  The majority of strains  as  in  the  earlier 
work were isolated from cases at the Harlem and Bellevue Hospitals.  1 
In this study nineteen additional types were identified which were 
termed Types XIV to XXXII,  continuing the numbering from the 
Types I, II and III of the early investigators and the types called IV 
to XIII by us. 
These types were correlated as far as we were able  with the types 
described by others.  The similarities of the whole classification are 
as follows:-- 
Type IV--Pn. 10, Griffith (2); Group IV B, Robinson (3). 
Type V--Sub. II A, Avery (4); Group IV E, Robinson (3). 
1  We are indebted to Dr. J. G. M. Bullowa,  Miss C. Wilcox  and Miss E. Green- 
baum at the Harlem Hospital and to Dr. R. L. Cecil, Dr. N. Plummer, Dr. A. 
Raia and Miss S. Schultz at the Bellevue Hospital for the case histories and the 
strains and wish to express our appreciation of their generous cooperation. COOPER~ ROSENSTEIN, WALTER~ AND PEIZER  533 
Type VI--Sub. II B, Avery (4). 
Type VIII--Group IV A, Robinson (3); Atypical III, Sugg, Gaspari, Fleming 
and Nefll (5). 
Type XV--Pn. 98, Griffith (2). 
Type XXI--Pn. 160, Griffith (2). 
Type XXII--Pn. 41, Griffith (2). 
The cross-agglutination reactions of representative strains of each 
type with antisera for each of the types were studied.  The antisera 
of rabbits or horses or of both were used for these tests. 
The cross-agglutination and cross-protection reactions of Types II 
and V and of Types III and VIII have been discussed in the earlier 
report (1). 
A number of strains which were agglutinated slightly to moderately 
in Type VI (Sub. IIB  of Avery) antisera, were found to be aggluti- 
nated to titer in an antiserum prepared for one of the strains.  This 
antiserum agglutinated Type VI cultures to a marked degree.  The 
strains corresponding to the original Type VI strains, we have termed 
Type VIa.  The strains agglutinating to titer in the new antiserum 
and slightly to moderately in the original Type VI antiserum we have 
termed Type VI b.  At first we called the latter strains Type XXVI; 
but  later  changed  the  terminology; because,  on  account  of  their 
cross-reactions with Type VI, division of the strains into two types 
did not seem to be justified.  After further investigation, it may be 
found that the differences are negligible from a practical point of view 
and that by the use of a dominant strain for serum production, they 
can  be  disregarded.  Then  the  strains  can  be  classified  simply as 
Type  VI. 
Cross-protection tests were carried out with Type VIa  and Type 
VI b antisera.  Two Type VI b antisera, one having 200 and the other 
500 units, each had 100 units protection against Type VI a; Type VI a 
antisera having 500  units had 200  to 500 units against Type  VI b. 
On account of these strong cross-reactions it would seem to be feasible 
to group the strains of VIa and VI b together for serum treatment. 
Also, there were cross-agglutination reactions between Types VII 
and XVIII,  especially strong with the horse antisera and with the 
Type VII  strains  which had  been  selected for  immunizing horses. 
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of both types were less.  Cross-protection tests were carried out with 
horse and rabbit  antisera for these types.  The Type XVIII horse 
antiserum had 500 protection units both against a Type VII culture 
and against the homologous strain.  One Type XVIII rabbit  anti- 
serum had 20  units of protection against VII and 50  units against 
Type XVIII; another had 5 units against VII and 1000 units against 
Type XVIII.  A  Type VII horse antiserum had 5 protection units 
against XVIII and 200 units against Type VII.  Type VII antisera 
from rabbits had less than 1 unit of protection against Type XVIII 
and 200 units against Type VII.  The fact that the Type VII strain 
used for protection tests was considerably less virulent for mice than 
the Type XVIII strain may account for the discrepancy in the degree 
of cross-agglutination and  cross-protection.  We have tested many 
strains of Type VII and Type XVIII for their cross-agglutination re- 
actions and found them to differ considerably. 
There were moderate cross-agglutination reactions between Types 
XV and XXX.  We have not been able to carry out satisfactory cross- 
protection tests because of a lack of fully virulent test strains for these 
types. 
The strains examined in this study were isolated from sputa, throat 
cultures, blood, spinal fluid and postmortem cultures.  All the spinal 
fluid and blood cultures examined yielded only one serological  type. 
A few of the mouse heart cultures were found to contain two types. 
The findings in such cases with the type identification made at the 
hospital is as follows:  "Type III?" contained Types III and XVIII; 
"Type XIX," Types III and XIX; "Type IV," Types IV and XVIII; 
"unclassified," Types XIII and XVIII; "unclassified," Types IV and 
XXII; and "unclassified," Types XI and XIV.  In only one of these 
cases was it clearly evident which type was the more infective, i.e. 
the case in which Types IV and X~VIII were found in the culture made 
from the heart blood of the mouse inoculated with sputum; Type 
XVIII was isolated from the blood, pleural fluid and spinal fluid.  It 
is probable that in cases in which more than one type of pneumococcus 
is found, examination of blood taken during convalescence for anti- 
bodies for the different types would give helpful information. 
A  classification of  181  strains  isolated  from lobar pneumonia in 
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tests with Antisera IV to XX and of 97 strains isolated in the season 
of 1929 and 1930 with Antisera IV to XXIX.  In  the  1929-30  cases 
special attention was given to the presence of more than one type of 
pneumococcus.  The  separation  of  the  strains  into  types,  the  per- 
centage of all strains in each type and the number and percentage of 
deaths are given in Table I.  Types IV, V, VII and VIII were most 
prevalent,  constituting 50  per  cent of the total.  There was an in- 
crease in Type VI b cases in the late winter and spring of 1931.  This 
occurred after we had discontinued examination of all strains of the 
different types and  therefore we have no  figures as  to  the  relative 
number of cases caused by this type in that period.  In this series of 
cases  pneumococci and  B. friedlaenderi  were  found in  three  cases, 
pneumococci and tubercle bacilli in one, and two types of pneumococci 
in  eight.  The  organisms were found early in the disease and  it is 
impossible  to  tell  in  the  majority  of  the  cases,  from  the  data 
available,  whether  one  or  both  organisms  were  responsible for the 
infections. 
Sixty-eight strains isolated from lobar pneumonia in children in the 
season of 1928 and 1929 and sixty-eight strains isolated in the season 
1929 and 1930 were studied (Table II).  Types V, VIa and XIV were 
found most often and amounted to 39 per cent of the total.  Two or 
more  types were  found in  thirteen  of  the  lobar  pneumonia  cases. 
Types VIa  and XXIII occurred most often in such combinations. 
The r61e of the different types when more than one are present needs 
investigating.  The  case  mortality of  12  per  cent  (19  per  cent  in 
children under 2 years and 6 per cent in the older group) was low in 
comparison with the adult series. 
In their studies of the bacteriology  of pneumonia in children, Plummet, Raia 
and Schultz (6), using our antisera reported that 50 per cent of the strains were 
classifiable in Types I  to XIII; Types I  and VI were found most frequently, 
Type I occurring in 9.5 per cent of the cases and Type VI in 12.9 per cent.  In 
the later study (7), about 85 per cent of the strains were classifiable  in Types I to 
XXIV and Types I, IV, VI, VII, XIV and XVIII were most prevalent.  Also,  in 
order to test the reliability of the original type determination, strains isolated 
from different sources in the same child, as throat (swab), chest fluid, blood, 
sputum,  ear and organs postmortem, were examined.  There were a  few dis- 
agreements; but the findings, in general, confirmed the validity of the original 
typing. ~6  SEPARATION OF TYPES OF GROUP IV PNE~OCOCCI 
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In the course of our work, examinations were made of a  few strains 
from normal individuals and from respiratory conditions other than 
pneumonia.  The  distribution of  those  which  could be classified  is 
TABLE  III 
Grouping o/Strains of Pneumococci o/So Called Group IV /rom Normal Individuals, 
from  Respiratory  Cases Other than  Pneumonia  and  from  Pneumococcus 
Meningitis 
Types  From normal  individuals  From  respiratory  cases  From pneumococcus 
other than  pneumonia  meningitis 
IV 
V 
VI a 
VI b 
VII 
VIII 
IX 
X 
XI 
XII 
XIII 
XIV 
XV 
XVI 
XVII 
XVIII 
XIX 
XX 
XXI 
XXII 
XXIII 
XXIV 
XXV 
XXVII 
XXVIII 
XXIX 
XXX 
XXXI 
XXXII 
2 
4 
9 
0 
1 
5 
1 
1 
3 
0 
2 
0 
1 
1 
1 
2 
8 
0 
0 
0 
1 
1 
0 
1 
0 
0 
0 
0 
0 
given  in Table  III.  Types  VI  a  and  XIX  were  most  prevalent. 
About  30 per cent  of  the  strains were unclassifiable in  the antisera 
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Webster and Hughes (8), employing antisera for Types I to XXV in a study 
of the incidence and  spread  of pneumococcus types in  normal persons,  found 
Types III, XIII and XIV most prevalent. 
Plummet,  Raia and Schultz  (6), testing  with antisera  for Types I  to XIII, 
found Type VI most prevalent  and Type III next in number, in children who 
did not have pneumonia. 
Dr.  Griffith  ~ in England,  found representatives  of the majority of the types 
in the healthy population of a boys' school. 
Dr. Wilson G. Smillie  *  studied the incidence of pneumococcus types in St. John, 
Virgin Islands,  and with antisera  for Types I  to XVIII found the majority of 
these types present  there. 
These  results  show that  the  pneumococcus types found  in  lobar 
pneumonia  cases may be found in  normal  individuals  and  that  the 
types found in New York are also present in distant localities.  Types 
III,  VI a,  XIII,  XIV and XIX,  during  the period of these studies, 
apparently were more prevalent in normal individuals in this locality. 
The classification of strains  from pneumococcus meningitis  also is 
given in Table III.  Fourteen  of the  recently separated  types were 
found.  Type XVIII, found in four cases, outnumbered the others. 
Preparation of Diagnostic Antiseta 
Antisera for determination of types have been prepared in quantity 
for nearly all the representative strains by inje.ction of horses.*  It is 
our  plan  to  have  sufficient  antisera  available  for  carrying  out  the 
identification  of types in  hospital  laboratories  by ordinary  routine 
methods.  Also, we plan to preserve representative strains of all types 
over a  considerable period of time and  to furnish  these  strains  and 
small amounts of homologous antisera to investigators who are study. 
ing the incidence of pneumococcus types in  other localities,  in order 
that the general distribution of the types may be determined and the 
classifications of other workers may be correlated with ours.  As we 
pointed out in our earlier paper,  Group IV strains isolated from va- 
rious conditions had been studied by different workers; but, with few 
exceptions, strains  of the types separated by them could not be ob- 
2  Personal communication. 
3  The immunization of horses for pneumococcus antisera  was carried out by 
Dr,  G. W. Welton and  Dr. E.  M.  Schryver at the New York City Antitoxin 
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tained.  We believe it is very desirable to preserve a  set of represent- 
ative type strains. 
Preparation of Therapeutic A ntisera 
Therapeutic  antisera  for  fourteen  types  have  been  prepared  for 
clinical triM. 
The potency of these was calculated in units per cc. on the basis  that a unit 
is ten times the smallest  amount of antiserum that protects a majority of mice 
against approximately 100,000 fatal doses  of culture.  As soon as expedient, a 
lot of antiserum for each type was carefully titrated and adopted as a standard. 
All preparations were then compared with the standard  antiserum which  was 
included as a  control in each set of protection titrations.  It is apparent that 
antisera for different types, having equal values in units as calculated by this 
method, are not necessarily of equal therapeutic value in human cases; because 
the test cultures for the types differ in their virulence for mice and the virulence 
of pneumococci of different types for mice does not correspond to their virulence 
for human beings.  Estimations in units are of value because they permit com- 
parison of the relative potency of different antisera  for the  same  type.  The 
comparative value of the antisera for different types for treatment of pneumonias 
of human beings can only be found by clinical trial. 
Laboratory tests made in an earlier study (1) indicated that thera- 
peutic antisera for Types I  and II had very little value in infections 
caused by heterologous types.  These antisera,  having  1000 to 2000 
protective units  for the types injected, usually had less than  1 unit 
against heterologous types as calculated by tests in mice.  The highest 
cross-protection was by a  Type II serum against Type V, amounting 
to about 20 units.  In our recent work, with antisera for some of the 
new types, we have encountered instances of greater cross-protection; 
for example, Types XVIII and VII discussed above.  The early work 
with Type I  indicated that therapeutic antisera for that type should 
have at least a  certain minimum potency (0.2 cc. of antiserum should 
protect against 0.1 cc. of highly virulent culture), which is equivalent 
to about 50 to 100 units per cc. as we now calculate the strength.  We 
have found that antisera for Type I  having 1000 units or more can be 
obtained in certain horses after immunization for 8 months or longer. 
It is probable that many of the antiserum preparations  which were 
used in the early clinical trial were several times,  perhaps  even ten 
to  twenty  times,  the  minimum  strength.  It  is  our  belief that  the COOPER~  ROSENSTEIN,  WALTER,  AND  PEIZER  543 
stronger antisera are more efficacious than the weaker product because 
the  necessary  protective  units can  be  given  in  smaller  volume  and 
consequently less foreign proteins are injected.  Also, in severe cases 
more antibodies  can be given in a  dose than would  be possible with 
TABLE  IV 
The Devdopment  of Protecting Antibodies  in Horses in Response to Injections  of 
Types IV,  V,  VI a,  VII,  VIII, XVIII and XXII,  and Types I  and II 
Protection in units per cc. after immunization for the following  mos, 
Types 
2  4  6  8  10  12  14  16  18  20  22  24  26  28  30 
I(E 100  100  10~ 
t  s  213  5o  loo  so~  soolooo  lOO  so 
i 
lo~  100  200  xo~  xoo  loo  200  500 looo looo 
n  200  s00 100o I s00  s00  i 
100  200  200  200  200  200  500 1000 1000 
500 500  200 
100 20C 500  200 
100 20C 200  200 
22~I0~  200 500 
--  10~ 100  200  2(E  100  100  10C  100 
513 200  500  20C  500  500  75~  500  500  5~  500500  500 
200 !500 500 10013 1000 
--50 500 !500 1000 100C 1000 1000 100C 1000 750  50C  300 300 500 
100 200 200  500  500  100  500  50~  200 
--20 100 20{  500  500  500  500 
20  50 20£  500 100G 500  500  500  500  500  501] 1000 
50 100 10C  100  100  200  200  200  500  500  50t] 500200 500 100( 
50  5C  50  50  75  75  75  200'  200  20~  200200500  75( 
50 1013  100  100  200  i 200  500 
100 100  100  200  200[ 200  200  200 
I 
* Horse died within 2 months of the last bleeding reported. 
'f Horse 297 was ill for several months. 
:~ Horse 99 produced antisera having an average of 500 units per cc. in the period 
from 30 to 48 months after immunization. 
low grade antiserum.  At present  we have selected  500  units  as  the 
minimum strength for our Type I  and II preparations.  We are try- 
ing  to produce  antisera  for the  other  pneumococcus types which  by 
laboratory tests will be equal to high grade Type I antiserum. 
Moderate  amounts of therapeutic  antisera have been prepared for 544  SEPARATION  OF TYPES OF  GROUP  IV PNEUMOCOCCI 
Types IV, V, VIa  and b, VII, VIII, IX, X, XlII,  XIV, XV, XVII, 
XVIII,  XX  and  XXII.  These antisera were usually  concentrated  4 
in order that as potent products as possible could be made from the 
moderate number of bleedings available. 
The stimulation  of antibodies in horses inoculated with Types IV 
to XXII  was similar in general to that with Types I  and II as far as 
could be judged by agglutination,  precipitation and protection tests 
(Table IV).  For some types  , antisera were as easily prepared as for 
Type I; for others, there was more difficulty as for Type II; but none 
of  those  studied  apparently  offer  as  great  difficulty  as  Type  III. 
Where we have sufficient data,  the potency of the antisera produced 
for each type is given in the summary of results with each type. 
Summary of Results with Each Type 
The data collected for each type as to prevalence, severity of cases 
and the production of antisera during the whole period of the study 
are summarized below. 
We have described the virulence of the strains as fully, very highly, highly, 
moderately, slightly virulent and non-virulent.  "Fully" indicates that  1 to 5 
diplococci, as determined by colony count in poured plates, killed mice in 3 days 
or less;  "very highly" indicates that 1 to 50 diplococci killed in 4 days or less; 
"highly" indicates that 50 to 500 diplococci killed in 4 days or less; "moderately" 
that 500 to 500,000 killed in less than 4 days; "slightly" that 500,000 to 5,000,000 
were required to kill. 
Type IV (Pn. 10, Gr{~ith; Group IV B, Robinson).--Fifty-seven strains from 
lobar  pneumonia  of adults  were  studied.  Thirty-four cases  from which  this 
type was isolated were rated as severe, twenty-three as moderate or mild.  Nine- 
teen patients died,  of whom nine were shown  to have positive blood cultures. 
Three patients shown  to have positive blood cultures recovered.  One patient 
developed a  Type IV meningitis.  This type was  found in  six  cases  of lobar 
pneumonia in children.  Five cases were moderate in severity.  One child  who 
was shown to have a positive blood culture died.  Type IV was one of the more 
prevalent types in adults and less prevalent in children. 
Examination of further Type IV strains supported our earlier observation that 
they are generally fully virulent for mice.  There was no difficulty in maintaining 
4 The concentration of the  antisera  was  carried out under the  direction of 
Dr. L. D. Felton at the Harvard Medical School or Dr. E. J. Banzhaf at the 
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the virulence of the strain used in determining the potency of antlsera by mouse 
protection tests. 
Antisera for Type IV prepared in horses averaged between 100 and 200 units 
per cc.; after immunization for l½ years, the antiserum of one horse had 500 units. 
Concentrated  preparations made  from  early  bleedings had  800  to  1200  units 
per cc.  It is possible that the potency of these antisera, as estimated by pro- 
tection tests in mice, is uniformly low because of the high virulence of the test 
strains for mice.  The agglutination and precipitation titers, however, were not 
especially high. 
The  polysaccharides of  Type  IV  have  been  studied  by  Heidelberger and 
Kendall (9).  They found a  type-specific carbohydrate which was different from 
those of Types I, II and III, a  carbohydrate which was chemically similar but 
was inactive in specific reactions and a  species-specific polysaccharide "C" sub- 
stance found also in Types I, II and III by Tillett, Goebel and Avery (10). 
Type V (Sub. II A, Avery; Group IV E, Robinson).--Forty-five strains  from 
lobar  pneumonia  of  adults  were  studied.  Thirty-one  cases  were  severe  and 
fourteen were mild.  Nineteen patients died, including fourteen who were shown 
to have positive blood cultures.  Five patients from whom positive blood cultures 
were obtained, recovered.  This type was found in sixteen cases of lobar pneu- 
monia of children.  Thirteen cases were moderate in severity; three were severe. 
Two  children died of whom  one  was shown  to  have  a  positive blood culture. 
Type V  was one of the more prevalent types in the pneumonias of both adults 
and children. 
This type was found to be the probable causative agent of an epidemic of colds, 
bronchitis and pneumonia in a children's home (11). 
Type V strains when grown in blood broth had a greater tendency to hemolyze 
blood cells than the other types studied.  A  special avidity for blood cells may 
account for the fact that there was a large percentage of positive blood cultures 
in Type V cases. 
After immunization of horses for 8 months antisera were obtained which had 
500 to 1000 units per cc.  The agglutination and precipitation titers of the sera 
also were high.  When the antiserum was concentrated ten times using methods 
which were successful with the antisera  of the majority of the other types, the 
loss  was  great;  the finished preparation having  only 500  to  1000  units.  The 
development of a  method for concentrating this type antisera  which will ensure 
a  good recovery is needed. 
Strains of this type were moderately virulent for mice.  The maintenance of 
the test strain in a fully virulent condition required very frequent mouse passage. 
Because of the marked cross-reactions of many Type V  strains with Type II 
antisera and vice versa, it would be desirable, in order to avoid mistakes, where 
serum treatment is to be given to cases of either type or a  careful study is to be 
made of their prevalence and prognosis, to titrate all strains reacting with either 
antiserum with antisera for both types.  Perhaps it will be advissble to have the 546  SEPARATION  OF TYPES  OF GROUP  IV PN-EU~IOCOCCI 
antiserum preparations for  treatment potent for  both  types.  We  are  under- 
taking the preparation of such  antiserum.  It will take a  long while to collect 
sufficient statistics to make a comparison of the relative therapeutic value of any 
of these new antisera and Type I  antiserum.  We have received favorable case 
reports however, that indicate Type V antiserum is probably of value. 
Type VIa (Sub. II B, Avery).--This type was found in eighteen cases of lobar 
pneumonia of adults.  Five were rated as severe, thirteen as mild.  Three of four 
patients who died were shown to have positive blood cultures.  This type was 
found in twenty cases of lobar pneumonia in children.  Five cases  were severe; 
fifteen were moderate.  Two children died.  Type VIa  was frequently found 
also in normal individuals and in respiratory conditions other than pneumonia. 
Type VIa  strains were  generally slightly to  moderately virulent for mice. 
Frequent mouse passage was required to keep the test culture fully virulent. 
The antiserum produced from a horse which was immunized during a period of 
nearly 2  years was  comparatively low in value having only 100  to  200  units. 
The agglutination and precipitation titers were  correspondingly low.  Concen- 
trated serum preparations were obtained which had 800  to  1000 units per cc. 
The immunization of another horse has been more successful, the antiserum of 
this horse having 500 units after immunization  for 8 months and 1000 units after 
a year and a half.  The difference in the response of these two horses to immuniza- 
tion  with  Type  VI  is  noteworthy.  We  have  encountered similar difference, 
however, in horses immunized with Types I and II.  The reason is not apparent. 
It is not because of an inherent inability to produce antibodies, for several of 
the horses which have not responded well to immunization with pneumococci 
have produced potent antiserum when inoculated with other organisms. 
Type VI b.--Data were obtained on eight cases of lobar pneumonia in adults. 
Five cases were rated as severe and three as moderate.  Four patients died, two 
of whom were shown to have positive blood cultures.  This type was found in 
the spinal fluid of a  case of meningitis following a  fractured skull.  A case in a 
baby 9 months old was moderate in severity. 
The strains were generally moderately virulent for mice. 
On account of the strong cross-reactions of Types VI a and VI b, a Type VIa 
horse was given injections of both types.  This horse whose serum had a potency 
of 500 units against Type VIa and 100 units against Type VI b, after 3 months 
immunization  with both types had 500 units per cc. and after 6 months had 1000 
units per cc. against each type. 
Type  VII.--Type  VII was found in forty-seven cases of lobar pneumonia in 
adults.  Twenty-six cases were rated as severe, nineteen as moderate.  Twelve 
patients died of whog~ five were shown to have the organism in the blood stream. 
Two patients shown to have positive blood cultures recovered.  Type VII was 
isolated from two spinal fluids sent to us for examination.  This type was found 
in six lobar pneumonias of children; one case was severe, the others moderate or 
mild.  This type was prevalent in the pneumonias of adults but rare in those 
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Antisera having 500 to 1000 units were obtained from horses after 6 to 8months 
immunization.  We are not sure whether it was by chance or because of a suscepti- 
bility of horses to inoculation with this strain that  there were many deaths of 
horses being immunized with this type.  The method of concentrating antisera 
of this type as of Type V requires further investigation.  Only 500 to 1000 units 
per cc. of protective antibody were recovered in preparations in which the serum 
was concentrated ten times. 
Strains of this type usually were moderately virulent for mice.  The test strain 
required very frequent passages to maintain full virulence. 
Reports of the serum treatment  of cases caused by this type have been en- 
couraging. 
Type VIII (Group IV A, Robinson; Atypical III, Sugg, Gaspari, Fleming and 
Neill).--This  type  was  isolated from  thirty-one  cases  of  lobar pneumonia  in 
adults.  Twelve cases were rated as severe, sixteen as moderate; eight patients 
died.  Five of seven patients which were shown to have positive blood cultures 
died.  Two  pneumonia  cases developed meningitis and  Type VIII was  found 
in the spinal fluids.  This type was found in three cases of lobar pneumonia in 
children;  two  were  mild; one  child  who  was  shown  to  have  a  positive blood 
culture, died. 
Long periods of immunization were required to obtain antiserum of suitable 
potency for this type.  Antisera having 100  to 300 units per cc. were obtained 
from  two horses after they had been immunized for 8  months.  Concentrated 
antisera were prepared having 800 to 1500 units per cc. 
The strains of this type generally were fully virulent for mice.  No special care 
was necessary to maintain the virulence of the test strain. 
There are marked cross-reactions between this type and Type III.  Differences 
in  colony morphology, however,  clearly differentiate strains of this  type from 
freshly isolated Type III strains.  We have never found Type VIII to have the 
large mucoid colonies characteristic of Type III.  If agglutination and precipita- 
tion reactions are chiefly relied upon for identification of Type III strains, Type 
VIII may be confused with it.  We believe that titrations of strains reacting with 
either type should be made with both antisera. 
Type IX.--Type IX was isolated from sixteen cases of lobar pneumonia in 
adults.  Seven were rated as severe, nine as moderate.  Seven patients died in- 
cluding  two  which  were  shown  to  have  positive blood cultures.  One  patient 
shown to have a  positive blood culture recovered.  This type was isolated from 
three cases of lobar pneumonia in children; two cases were moderate in severity; 
one child died. 
Antisera having 200 units per cc. were prepared in one horse.  Concentrated 
antisera having 1000 units per ce. were prepared from this antisera. 
Strains of this type generally were only slightly virulent for mice. 
A suitable test strain was discovered only after prolonged search. 
Type X.--This type was isolated from thirteen cases of lobar pneumonia of 
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two of these were shown to have positive blood cultures.  One patient having a 
positive blood culture recovered.  Type X  was isolated from the spinal fluid of 
one meningitis case sent  to  us  for examination.  This  type was  found  in  two 
cases of lobar pneumonia in children; one case was mild and the other terminated 
fatally. 
The strains were of low virulence for mice. 
Type  XI.--This type was isolated from ten adult  cases, of which four were 
severe and six moderate.  Three patients died.  One case from which a positive 
blood culture was obtained was rated as moderate in severity.  This type was 
isolated from five lobar pneumonia cases in children; three cases were moderate in 
severity; two were severe; of the latter, one terminated fatally. 
Antisera were prepared having 200 to 500 units per cc. 
The strains were moderately to fully virulent for mice. 
Type XII.--This type was found in twelve cases of lobar pneumonia in adults; 
six were rated as severe and six as moderate.  Four patients died; of whom three 
were shown to have positive blood cultures.  Type XII was found in two spinal 
fluids sent  for examination.  This  type  was  isolated  from  two severe cases  of 
lobar pneumonia in children. 
The strains were generally of low virulence for mice. 
Type XIII.--This type was isolated from fourteen cases of lobar pneumonia 
of adults.  Seven were rated as severe and seven as moderate.  Three patients 
died; two of these were shown to have positive blood cultures.  This type was 
isolated from one child having a mild lobar pneumonia. 
Type XIII was found by Webster (8)  to be one of the most prevalent types in 
the normal individuals which he studied. 
The strains which we examined were slightly to moderately virulent for mice. 
Type  XIV.--This  type  which  was  one  of  the  most  prevalent  types  in  the 
pneumonias of children was found in only five pneumonia cases of adults.  Three 
were severe and two mild.  Two patients died, of whom one was shown to have 
a  positive blood culture.  Type XIV was found in one spinal fluid sent for ex- 
amination.  This type was isolated from nineteen cases of lobar pneumonia in 
children.  Seven cases  were  rated  as  severe and  twelve as  moderate  or  mild. 
Four children died; of whom three were shown to have positive blood cultures. 
The strains of this type were moderately virulent for mice. 
Type XV (In. 98; Gri~th).--This type was found in only four cases of lobar 
pneumonia of adults, two were severe and two moderate.  One patient who was 
shown to have a positive blood culture died.  This type was found in seven cases 
of lobar pneumonia in children; six were mild and one was severe. 
With one exception the few strains  which we had  of this  type were slightly 
virulent for mice. 
Type XVI.--This  type  was  found  very infrequently.  It  was  found  in  two 
adult cases; one patient having a positive blood culture died; the other case was 
mild.  It was found in two lobar pneumonias of children. 
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Type XVII.--Strains were obtained from six cases of which four were severe 
and two moderate.  Two patients died, of whom one was shown to have a positive 
blood culture.  This type was found in four lobar pneumonia cases in children; 
one was severe, the others were mild. 
The strains were slightly to moderately virulent for mice. 
Type XVIII.--Strains from twelve cases  of lobar pneumonia in adults were 
studied.  Ten cases  were severe and two moderate.  Six patients, all of whom 
were shown to have positive blood cultures, died.  One of the above patients 
developed meningitis and Type XVIII was isolated from the spinal fluid.  This 
type was isolated from four spinal fluids sent to us for diagnosis.  It was found 
in five lobar pneumonia  cases in children; one was severe; the others were moderate 
or mild. 
Type XVIII strains were moderately to fully virulent for mice.  The virulence 
of our test strains has been maintained without difficulty. 
The one horse immunized with this type produced antiserum having 500  to 
1000 units per cc.  Because of the cross-reactions between Types VII and XVIII 
this horse was transferred to inoculations of both types and after a  few months 
had  1000  units per  cc.  against Type VII and 500  units per cc.  against Type 
XVIII.  Concentrated refined antiserum having 5000 units against Type XVIII 
was prepared from the monovalent antiserum. 
Type XIX.--Type  XIX was isolated from six cases of lobar pneumonia of 
adults of which five were severe and one moderate.  One patient shown to have 
the organism in the blood died.  This type was isolated from seven lobar pneu- 
monia cases in children; three cases  were severe; four were moderate or mild. 
It was found moderately prevalent in normal individuals. 
The strains were moderately virulent for mice. 
Type XX.--This type was isolated from seven cases of lobar pneumonia in 
adults.  Three were rated as severe and two as moderate.  Two patients shown 
to have positive blood cultures recovered.  This type was found in three lobar 
pneumonia cases in children; two were severe and one was mild.  One child died. 
The strains of  this type differed markedly in their  virulence for mice,  the 
majority of the strains being moderately virulent. 
Type XXI (Pn. 160, Gri~th).--Three strains of this type from  lobar  pneu- 
monia of adults were studied.  Two cases were rated as severe and one as mod- 
erate.  Two patients died, of these one was shown to have the organisms in the 
blood and spinal fluid.  This type was isolated from one mild lobar pneumonia 
in a  child. 
The strains of this type were generally slightly virulent for mice. 
Type XXII (Pn. 41, Gri~h).--This type was isolated from two mild cases of 
lobar  pneumonia of  adults.  It  was  found in  two  lobar pneumonia cases  in 
children; one was severe and the other mild.  Griffith,  ~ in England, found this 
type in a number of normal individuals. 
An antiserum having 500 units per cc. was prepared after immunization of a 
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Strains of this type generally were very highly virulent for mice but tended to 
lose their virulence rapidly. 
Type XXIII.--Seven strains of this type from lobar pneumonia of adults were 
studied.  Six  of the cases were severe and one moderate.  Two patients died, 
one of whom was shown to have positive blood culture.  One patient who had a 
positive blood  culture recovered.  This  type  was  isolated  from  five  cases  in 
children; two were mild and three severe; one of the latter terminated fatally. 
It  was  found also in the spinal fluid of  a  child who  developed posttraumatie 
meningitis. 
The strains of this type were generally slightly to moderately virulent for mice. 
Type XXIV.--This type was isolated from five moderately severe lobar pneu- 
monias of adults and from one fatal case that had B. friedtaenderi in the blood. 
It was isolated also from a spinal fluid sent to us for examination. 
Grififith,  ~ in England, found this type in a  moderate number of normal indi- 
viduals. 
Strains of this type were moderately to fully virulent for mice. 
Type XXV.--Five strains from the lobar pneumonia of adults were studied. 
Two patients died, both of whom were shown to have positive blood cultures. 
Three cases were rated as moderate. 
Strains of this type were generally very highly virulent for mice. 
Type XXVII.--This type was isolated from two moderately severe cases of 
lobar pneumonia in adults.  It was also found in a spinal fluid sent for diagnosis 
and in a case of follicular tonsilitis and a case of measles. 
The few strains examined were moderately to very highly virulent for mice. 
Type XXVIII.--Four cases of lobar pneumonia in adults were moderate in 
severity. 
The strains examined were very different in their virulence for mice, ranging 
from slightly virulent to fully virulent. 
Type XXIX.--We have data on three adults, one died and two  eases were 
severe.  This type was found in three mild cases of lobar pneumonias of children. 
The strains were very irregular in their virulence for mice, the majority however 
being highly virulent. 
Type XXX.--We have data on three mild cases in children. 
Three  strains were  examined for  their  virulence for  mice;  one  was  highly 
virulent, one moderately virulent and the other non-virulent. 
Type XXXI.--We have data on two cases in adults from which this type was 
isolated; one had lobar pneumonia of moderate severity, the other died. 
The strains examined were moderately virulent for mice. 
Type XXXII.--We have not been able to get data on cases from which this 
type was isolated. 
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DISCUSSION 
The difference in the incidence of cases and in the relative severity 
of the infection caused by the different types indicates that all  the 
types are not of equal importance, and it is questionable whether it is 
practical to attempt to produce therapeutic antisera for those which 
are less prevalent and less virulent.  Although there is no immediate 
benefit to individual patients in determining the type where no thera- 
peutic serum is available, it seems worth while to continue examination 
for all  the  types and maintain a  full  supply of  diagnostic antisera 
until it is learned whether there is a seasonal and periodical variation 
in the types in this locality and what their distribution in other locali- 
ties is.  The statistics which have been collected by others in regard 
to the prevalence of Types I, II, III and Group IV indicate that such 
variation occurs.  For example Griffith (12)  found the incidence of 
the  pneumococcus types  in  the  Smethwick district  in  England as 
follows:-- 
t  Type I  Type n  Type III  Group  IV 
Apr.,1920-Jan.,1922  .....................  I  30'6  I  32"6  I  6.6  I  30.0 
Feb.,1922-Oct.,1924  .... .................  [  426  I  2i3  [  3.2  I  n.7 
Nov., 1924-Mar.,  1927 ...................  [  34.3  [  2.4  ]  4.4  t  53.7 
In the third period there was a  decrease in Type II cases and an 
increase in Group IV cases.  An interesting study which was carried 
out with several antisera other than those generally used is that re- 
ported by Ordman  (13)  where different types of pneumococcus as 
well as different organisms were found predominating in the pneu- 
monias of the Witwatersrand miners in South Africa during a period of 
15 years. 
An observation that some of the types, found most frequently in 
the pneumonias of adults, were found seldom in children and vice versa 
needs  study.  The  theory  that  children become infected with  the 
types which are most widespread in normal individuals is not sup- 
ported by the facts observed; for example, although Type VI a, one of 
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most prevalent in the pneumonias of children, Type I, which was com- 
paratively rare in normal individuals, also was very frequently found. 
The observation that the majority of the types found in normal indi- 
viduals are not found in the pneumonias of adults may be explained 
in different ways; as by a lack of virulence or invasive power of the 
strains; or, that because of the wide distribution of the strains,  the 
majority of individuals become relatively immune to them in early 
life.  Probably different explanations will  be  necessary for the be- 
havior of different types. 
A further study of the invasive powers of pneumococci is needed. 
The epidemic, among children in an institution, of colds,  bronchitis 
and pneumonias caused by Type V showed that this type has invasive 
capacity and should be classed as an infectious organism.  It seems 
likely that  under ordinary conditions, pneumococci are  responsible 
for a considerable percentage of mild respiratory conditions and that 
when the resistance of individuals is especially lowered, pneumonia is 
more apt to occur. 
Where more than one type of pneumococcus is found, their impor- 
tance in the infection needs to be investigated. 
The problem of the preparation of potent therapeutic antisera also 
needs further study.  First, there is the selection of suitable strains 
and methods of immunization.  It seems to be the general opinion 
that  strains of the highest virulence are most suitable,  an  opinion 
which is probably based on observations that degraded strains stimu- 
late the production of antisera which are often deficient in curative 
power.  Contrary to this opinion we have results as to the relative 
ability of freshly isolated virulent Type III strains having very large 
capsules and of less virulent stock Type III cultures having smaller 
capsules  to  stimulate  antibodies.  Antisera  more  potent  for  both 
kinds of strains as determined by laboratory tests were produced by 
inoculation of the less virulent cultures.  If the pneumococcus pro- 
duces a toxin in significant amount in human pneumonia, then strains 
of high toxin-producing power and probably the subcutaneous as well 
as the intravenous method of inoculation should be used.  However, 
at present, we believe convincing evidence of the existence of such 
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S~A.RY 
The unclassified strains known as Group IV have been separated 
into twenty-nine types which are designated by the Roman numerals 
IV  and  XXXII.  Only  a  small  percentage  of  the  pneumococcus 
strains isolated in New York City for this study were left unclassified. 
The majority of the types gave very slight cross-reactions, the ex- 
ceptions being Types II and V, III and VIII, VII and XVIII and XV 
and XXX. 
In the series of cases studied, Types IV, V, VII and VIII were found 
more prevalent in the lobar pneumonia of adults and Types V, VIa 
and XIV in children. 
The majority of the types were also found in normal individuals and 
in persons having respiratory infections other than pneumonia.  Types 
VI a and XIX were most prevalent in the limited number of strains 
studied by us. 
Fourteen of  the  types were  found in  pneumococcus meningitis; 
Type XVIII was found most often. 
Antisera suitable for clinical  trial have been prepared for fourteen 
types.  From the majority of the horses inoculated for more than a 
year, antisera having 500 to 1000 units per cc. were obtained.  Anti- 
sera of lower potency were concentrated and preparations obtained 
equal to or stronger than high grade unconcentrated serum. 
Potent bivalent antisera have been prepared for types which were 
found to give marked cross-agglutination reactions. 
The results with each type as to prevalence, severity of cases, pres- 
ence in normal individuals, and in spinal meningitis, potency of anti- 
sera produced for therapeutic trial and virulence of strains for mice 
have been considered under the different type headings. 
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